# Treatment of Hemochromatosis

> **NCT00007150** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 622 (actual)

## Conditions studied

- Hemochromatosis

## Interventions

- **PROCEDURE:** Phlebotomy

## Key facts

- **NCT ID:** NCT00007150
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2001-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 622 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007150, "Treatment of Hemochromatosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00007150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*